二酶7:在卵巢癌中是一种潜在的新型治疗标
Nayara Gusmão Tessarollo1, Isabella Dos Santos Guimarães2, Diandra Zipinotti Dos Santos1
1Biotechnology Program/RENORBIO, Health Sciences Center, Federal University of Espírito Santo, Vitória, Espírito Santo, Brazil.
Frontiers in pharmacology
|June 19, 2025
概括
用BRL 50481向化酶7A (PDE7A) 提高了帕克利塔塞尔在卵巢癌中的疗效. 这种组合疗法通过促进亡和抑制生存途径来克服化学抵抗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 表皮卵巢癌 (EOC) 由于化疗抵抗而经常复发,需要新的治疗点.
- 二酶7A (PDE7A) 作为卵巢癌的潜在治疗标正在研究中.
研究的目的:
- 为了研究抑制PDE7A的疗效,使用BRL 50481,单独或与帕克利塔塞尔 (PTX) 结合,用于治疗卵巢癌.
- 阐明PDE7A抑制在增强化疗反应的基础上的分子机制.
主要方法:
- 通过RNA测序进行基因表达分析.
- 对药物敏感 (A2780) 和耐药 (OVCAR3) 卵巢癌细胞进行细胞活力测试 (MTT).
- 使用RT-qPCR,免疫结血,ELISA和电子显微镜进行验证.
主要成果:
- 与PTX相结合的BRL 50481显著降低了细胞活力,并在两个细胞系中降低了帕克利塔塞尔IC50.
- 抑制PDE7抑制PI3K/AKT/mTOR通路,并对BAX进行上调,从而促进细胞亡.
- 组合疗法诱导了形态和线粒体的变化,降低了维门丁和OCT4.4的调节.
结论:
- 抑制PDE7A通过诱导线粒体功能障碍和抑制生存途径,增强卵巢癌中帕克利塔塞尔诱导的亡.
- 抑制PDE7A是一种有前途的策略,可以提高帕克利塔塞尔在治疗抗化学药性卵巢癌中的疗效.
- 需要在体内模型中进行进一步的验证.
相关概念视频
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
02:54Protein Kinases and Phosphatases
13.5K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.5K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:01Phosphodiester Linkages
103.9K
Overview
Phosphodiester bond forms when a phosphoric acid molecule (H3PO4) links with two hydroxyl groups (–OH) of two other molecules, forming two ester bonds. Two water molecules are released in this process. The phosphodiester bond is commonly found in nucleic acids (DNA and RNA) and plays a critical role in their structure and function.
Phosphodiester Bonds Link Nucleotides Together
DNA and RNA are polynucleotides or long chains of nucleotides that are linked together. A nucleotide is...
Phosphodiester bond forms when a phosphoric acid molecule (H3PO4) links with two hydroxyl groups (–OH) of two other molecules, forming two ester bonds. Two water molecules are released in this process. The phosphodiester bond is commonly found in nucleic acids (DNA and RNA) and plays a critical role in their structure and function.
Phosphodiester Bonds Link Nucleotides Together
DNA and RNA are polynucleotides or long chains of nucleotides that are linked together. A nucleotide is...
103.9K